Answers are grounded in this paper and cite their sources.
In the world, there are many tests that allow the detection of HPV infection. These tests are based on different operating principles and have different levels of sensitivity. The first test to detect HPV infection was approved by the Food and Drug Administration in 2003. Since then, the FDA has approved five more commercial tests for this purpose, the last one in 2018. This paper discusses the principles of molecular tests to detect HPV, which have been approved by the FDA, the main differences between them, as well as their advantages and disadvantages.
No takes yet. Share an insight, caveat, or question.
Sitarz et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: